These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 14693730

  • 1. Endogenous sex hormones and prostate cancer risk: a case-control study nested within the Carotene and Retinol Efficacy Trial.
    Chen C, Weiss NS, Stanczyk FZ, Lewis SK, DiTommaso D, Etzioni R, Barnett MJ, Goodman GE.
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1410-6. PubMed ID: 14693730
    [Abstract] [Full Text] [Related]

  • 2. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
    Platz EA, Leitzmann MF, Rifai N, Kantoff PW, Chen YC, Stampfer MJ, Willett WC, Giovannucci E.
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683
    [Abstract] [Full Text] [Related]

  • 3. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C, Secreto G, Amiano P, Bingham S, Boeing H, Bueno de Mesquita HB, Chang-Claude J, Clavel-Chapelon F, Fournier A, van Gils CH, Gonzalez CA, Gurrea AB, Critselis E, Khaw KT, Krogh V, Lahmann PH, Nagel G, Olsen A, Onland-Moret NC, Overvad K, Palli D, Panico S, Peeters P, Quirós JR, Roddam A, Thiebaut A, Tjønneland A, Chirlaque MD, Trichopoulou A, Trichopoulos D, Tumino R, Vineis P, Norat T, Ferrari P, Slimani N, Riboli E.
    J Natl Cancer Inst; 2005 May 18; 97(10):755-65. PubMed ID: 15900045
    [Abstract] [Full Text] [Related]

  • 4. Circulating steroid hormones and the risk of prostate cancer.
    Severi G, Morris HA, MacInnis RJ, English DR, Tilley W, Hopper JL, Boyle P, Giles GG.
    Cancer Epidemiol Biomarkers Prev; 2006 Jan 18; 15(1):86-91. PubMed ID: 16434592
    [Abstract] [Full Text] [Related]

  • 5. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
    Tworoger SS, Missmer SA, Barbieri RL, Willett WC, Colditz GA, Hankinson SE.
    J Natl Cancer Inst; 2005 Apr 20; 97(8):595-602. PubMed ID: 15840882
    [Abstract] [Full Text] [Related]

  • 6. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M, Hankinson SE.
    J Natl Cancer Inst; 2006 Oct 04; 98(19):1406-15. PubMed ID: 17018787
    [Abstract] [Full Text] [Related]

  • 7. The association between lung and prostate cancer risk, and serum micronutrients: results and lessons learned from beta-carotene and retinol efficacy trial.
    Goodman GE, Schaffer S, Omenn GS, Chen C, King I.
    Cancer Epidemiol Biomarkers Prev; 2003 Jun 04; 12(6):518-26. PubMed ID: 12814997
    [Abstract] [Full Text] [Related]

  • 8. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.
    Gann PH, Ma J, Giovannucci E, Willett W, Sacks FM, Hennekens CH, Stampfer MJ.
    Cancer Res; 1999 Mar 15; 59(6):1225-30. PubMed ID: 10096552
    [Abstract] [Full Text] [Related]

  • 9. V89L polymorphism of the 5alpha-reductase Type II gene (SRD5A2), endogenous sex hormones, and prostate cancer risk.
    Boger-Megiddo I, Weiss NS, Barnett MJ, Goodman GE, Chen C.
    Cancer Epidemiol Biomarkers Prev; 2008 Feb 15; 17(2):286-91. PubMed ID: 18268111
    [Abstract] [Full Text] [Related]

  • 10. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
    Beattie MS, Costantino JP, Cummings SR, Wickerham DL, Vogel VG, Dowsett M, Folkerd EJ, Willett WC, Wolmark N, Hankinson SE.
    J Natl Cancer Inst; 2006 Jan 18; 98(2):110-5. PubMed ID: 16418513
    [Abstract] [Full Text] [Related]

  • 11. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE.
    J Natl Cancer Inst; 2004 Dec 15; 96(24):1856-65. PubMed ID: 15601642
    [Abstract] [Full Text] [Related]

  • 12. Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Peters U, Leitzmann MF, Chatterjee N, Wang Y, Albanes D, Gelmann EP, Friesen MD, Riboli E, Hayes RB.
    Cancer Epidemiol Biomarkers Prev; 2007 May 15; 16(5):962-8. PubMed ID: 17507623
    [Abstract] [Full Text] [Related]

  • 13. Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk.
    Dorgan JF, Longcope C, Stephenson HE, Falk RT, Miller R, Franz C, Kahle L, Campbell WS, Tangrea JA, Schatzkin A.
    Cancer Epidemiol Biomarkers Prev; 1996 Jul 15; 5(7):533-9. PubMed ID: 8827358
    [Abstract] [Full Text] [Related]

  • 14. Endogenous sex hormones and the risk of prostate cancer: a prospective study.
    Weiss JM, Huang WY, Rinaldi S, Fears TR, Chatterjee N, Hsing AW, Crawford ED, Andriole GL, Kaaks R, Hayes RB.
    Int J Cancer; 2008 May 15; 122(10):2345-50. PubMed ID: 18172860
    [Abstract] [Full Text] [Related]

  • 15. Serial prostate specific antigen, free-to-total prostate specific antigen ratio and complexed prostate specific antigen for the diagnosis of prostate cancer.
    Ellis WJ, Etzioni R, Vessella RL, Hu C, Goodman GE.
    J Urol; 2001 Jul 15; 166(1):93-8; discussion 98-9. PubMed ID: 11435831
    [Abstract] [Full Text] [Related]

  • 16. Fatty acids and risk of prostate cancer in a nested case-control study in male smokers.
    Männistö S, Pietinen P, Virtanen MJ, Salminen I, Albanes D, Giovannucci E, Virtamo J.
    Cancer Epidemiol Biomarkers Prev; 2003 Dec 15; 12(12):1422-8. PubMed ID: 14693732
    [Abstract] [Full Text] [Related]

  • 17. Serum concentrations of estrogens, sex hormone binding globulin, and androgens and risk of breast hyperplasia in postmenopausal women.
    Schairer C, Hill D, Sturgeon SR, Fears T, Mies C, Ziegler RG, Hoover RN, Sherman ME.
    Cancer Epidemiol Biomarkers Prev; 2005 Jul 15; 14(7):1660-5. PubMed ID: 16030098
    [Abstract] [Full Text] [Related]

  • 18. Androgens in serum and the risk of prostate cancer: a nested case-control study from the Janus serum bank in Norway.
    Vatten LJ, Ursin G, Ross RK, Stanczyk FZ, Lobo RA, Harvei S, Jellum E.
    Cancer Epidemiol Biomarkers Prev; 1997 Nov 15; 6(11):967-9. PubMed ID: 9367072
    [Abstract] [Full Text] [Related]

  • 19. The protective effect of diabetes mellitus against prostate cancer: role of sex hormones.
    Baradaran N, Ahmadi H, Salem S, Lotfi M, Jahani Y, Baradaran N, Mehrsai AR, Pourmand G.
    Prostate; 2009 Dec 01; 69(16):1744-50. PubMed ID: 19676082
    [Abstract] [Full Text] [Related]

  • 20. Endogenous sex hormones and prostate cancer: a quantitative review of prospective studies.
    Eaton NE, Reeves GK, Appleby PN, Key TJ.
    Br J Cancer; 1999 Jun 01; 80(7):930-4. PubMed ID: 10362098
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.